Source: International Congress 2019 – Clinical challenges in respiratory infection
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
H. Yang (Barcelona, Spain), A. Motos (Barcelona, Spain), G. Li Bassi (Barcelona, Spain), E. Aguilera Xiol (Barcelona, Spain), F. Pagliara (Genoa, Italy), T. Senussi (Genoa, Italy), F. Idone (Roma, Italy), J. Bobi (Barcelona, Spain), R. Cabrera (Barcelona, Spain), L. Fernandez-Barat (Barcelona, Spain), M. Yang (Barcelona, Spain), D. Nicolau (Hartford, United States of America), P. Pelosi (Genoa, Italy), M. Antonelli (Roma, Italy), A. Torres (Barcelona, Spain). Efficacy of Ceftolozane/Tazobactam in Comparison with Piperacillin/Tazobactam in Severe Pseudomonas aeruginosa Pneumonia Swine Model. 4562

Member's Comments

No comment yet.

Related content which might interest you: Pseudomonas aeruginosa pneumonia in the community Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Ventilator-Induced Lung Injury Increases Systemic Inflammation in Murine Pseudomonas Aeruginosa Pneumonia Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment Year: 2019 Aminoglycoside use for pseudomonas aeruginosa in bronchiectasis Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Multidrug resistant acinetobacter baumanii pneumonia: Mortality analysis and comparison of intravenous versus aerosolized therapy Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Methicillin-susceptible Staphylococcus aureus in Community-Acquired Pneumonia: Risk Factors and Outcomes Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020 Monitoring of antimicrobial resistance respiratory strains of streptococcus pneumoniae Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014 Inoculation Pneumonia Caused by Coagulase Negative Staphylococcus in Mice Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video Source: International Congress 2014 – Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video Year: 2014 The synthetic streptococcus pneumoniae oligosaccharide conjugate protected mice from severe pneumonia Source: International Congress 2014 – Lung cell biology in injury and repair Year: 2014 LATE-BREAKING ABSTRACT: Molecular and Phenotypic Characters of Methicillin-resistant Staphylococcus aureus Isolates from Patients with Empyema Thoracis in Central Taiwan Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014 Clinical Efficacy and Cost-Effectiveness Analysis of Cefepime or Piperacillin/tazobactam both with Ciprofloxacin in MICU Patients with Severe Pneumonia Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment Year: 2019 Late Breaking Abstract - Biofilm formation by Pseudomonas aeruginosa in empyema Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020 Household Biomass Particulate Matter Increases Susceptibility to Streptococcus pneumoniae Infection Source: International Congress 2019 – Air pollution and the lungs Year: 2019 Comparative evaluation of timing of antibiotic intravenous-to-oral switch in pneumonia Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Emerging macrolide-resistant mycoplasma pneumoniae in Thailand Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014 Respiratory commensal streptococcus spp do not modulate the outcome of pseudomonas aeruginosa infection in vivo Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Community-acquired pneumonia due to multidrug and non-multidrug resistant pseudomonas aeruginosa Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Bronchial Lavage Exosome miRNA Correlates to Metabolic Disturbance in Patients with Pulmonary Acinetobacter Baumannii Infection Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Pseudomonas, enterobacteriaceae ESBL positive and staphylococcus MRSA: When to suspect them in CAP? Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Pseudomonas Aeruginosa Infection in Respiratory Samples in Children with Neurodisability – to treat or not to treat? Source: Virtual Congress 2020 – Aspects of acute and chronic airway infections in children Year: 2020